Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Peptide p277

Next Previous
X
Search
Drug Profile

Peptide p277

Alternative Names: AVE-0277; DiaPep-277; DiaPep277

Latest Information Update: 25 Sep 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Weizmann Institute of Science
  • Developer Andromeda Biotech; DeveloGen
  • Class Antihyperglycaemics; Heat shock proteins; Peptide fragments; Peptide vaccines
  • Mechanism of Action T lymphocyte modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Type 1 diabetes mellitus
  • New Molecular Entity No

Highest Development Phases

  • Suspended Latent autoimmune diabetes in adults; Type 1 diabetes mellitus

Most Recent Events

  • 30 Jun 2016 Andromeda Biotech completes a phase III extension trial for Type-1 diabetes mellitus in Israel (NCT00644501)
  • 17 Feb 2015 Hyperion CBI and Yeda enter into a final agreement in relation to the development of peptide p277
  • 07 Oct 2014 Hyperion Therapeutics and Clal Biotechnology Industries enter into an interim agreement in relation to the development of peptide p277

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top